The Influence of Gene Polymorphisms on Coronary Artery Disease

Roy H. , Bhardwaj S. , Yla-Herttuala S. Molecular genetics of atherosclerosis. Hum Genet.2009;125(5-6):467-491.

Rissanen AM Familial occurrence of coronary heart disease: effect of age at diagnosis . Am J Cardiol. 1979;44(1):60-66.

Roberts R. , Stewart AF , Wells GA , Williams KA , Kavaslar N. , McPherson R. Identifying genes for coronary artery disease: An idea whose time has come . Can J Cardiol. 2007;23 suppl A:7A-15A.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.

Kolovou G. , Anagnostopoulou K. , Mikhailidis DP , Cokkinos DV Apolipoprotein E. knockout models. Curr Pharm Des. 2008; 14(4):338-351.

Miyoshi T. , Tian J. , Matsumoto AH , Shi W. Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis . 2006;189(1):99-105.

Junyent M. , Gilabert R. , Jarauta E. , et al. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia . Atherosclerosis. 2008;(2):437-441.

Kolovou GD , Dedoussis GV , Anagnostopoulou KK , et al. Management of a patient with a null low-density lipoprotein receptor mutation: a case report. Angiology. 2006;57(6):729-732.

Kolovou GD , Anagnostopoulou KK , Karyofillis P. , et al. Cholesteryl ester transfer protein gene polymorphisms and severity of coronary stenosis. Clin Invest Med. 2006 ;29(1):14-19.

Wojtczak A. , Skretkowicz J. Genetic determinants in ischemic heart disease . Acta Pol Pharm. 2008;65(5):607-610.

Kolovou GD , Anagnostopoulou KK , Kostakou P. , et al. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease. In Vivo.2009;23(1):33-39.

Kolovou GD , Anagnostopoulou KK , Mikhailidis DP , et al. Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. Angiology. 2005;56(6): 663-670.

Kolovou GD , Anagnostopoulou KK Apolipoprotein E. polymorphism, age and coronary heart disease. Ageing Res Rev . 2007;6(2):94-108.

Ghatrehsamani K. , Darabi M. , Rahbani M. , Hashemzadeh Chaleshtory M. , Farrokhi E. , Noori M. Combined hepatic lipase514C/T and cholesteryl ester transfer protein I405V polymorphisms are associated with the risk of coronary artery disease. Genet Test Mol Biomarkers. 2009;13(6):809-815.

Reinhard W. , Stark K. , Sedlacek K. , et al. Association between PPARalpha gene polymorphisms and myocardial infarction. Clin Sci ( Lond). 2008;115(10):301-308.

Aitkhozhina NA , Liudvikova EK [Polymorphism of the promotor region of the angiotensinogen gene and the gene for angiotensin I-converting enzyme in arterial hypertension and myocardial ischemia of the Kazakh ethnic groups]. Genetika. 2003;39(2):293-299.

Karayannis G. , Tsezou A. , Giannatou E. , Papanikolaou V. , Giamouzis G. , Triposkiadis F. Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction. Angiology. 2010; in press (details to be completed when article pagination is available).

Ragia G. , Nikolaidis E. , Tavridou A. , et al. Renin-angiotensin-aldosterone system gene polymorphisms in coronary artery bypass graft surgery patients. J Renin Angiotensin Aldosterone Syst.2010;11(1):1-10.

Zintzaras E. , Raman G. , Kitsios G. , Lau J. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis . Arch Intern Med. 2008;168(10):1077-1089.

Cambien F. , Poirier O. , Lecerf L. , et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359(6396):641-644.

Arnett DK , Baird AE , Barkley RA , et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007; 115(22):2878-2901.

Anagnostopoulou K. , Kolovou G. , Kostakou P. , Mihas C. , Mikhailidis D. , Cokkinos DV Pharmacogenetic study of cholesteryl ester transfer protein gene and simvastatin treatment in hypercholesterolaemic subjects . Expert Opin Pharmacother. 2007;8(15):2459-2463.